News
Important Only
AbbVie to cut drug prices, pledges $100 billion for research
Jan 12 (Reuters) - AbbVie ABBV.N said on Monday that it has struck a three-year deal with U.S. President Donald Trump's administration to reduce drug prices, and has pledged $100 billion over the next decade for research and development in the country.The drugmaker said the investment will inclu...Reuters
Tue, Jan 13
Minnesota, Illinois sue Trump administration to block immigration surges
Tensions rise after fatal shooting by federal officer in MinnesotaMinnesota lawsuit challenges federal immigration enforcement surgeIllinois files similar lawsuit, asking court to halt certain operationsTrump administration says it is enforcing the law after Minnesota failed toBy Maria Alejandra Car...Reuters
Tue, Jan 13
Amgen Says 24-Week Study Of Monthly Maritide In People With Type 2 Diabetes Showed Robust, Clinically Meaningful Reduction In Both HBA1C, Weight
Jan 12 (Reuters) - Amgen Inc AMGN.O:AMGEN: 24-WEEK STUDY OF MONTHLY MARITIDE IN PEOPLE WITH TYPE 2 DIABETES SHOWED ROBUST, CLINICALLY MEANINGFUL REDUCTION IN BOTH HBA1C, WEIGHTAMGEN: "LARGE MAJORITY" OF PEOPLE IN 52-WEEK MARITIDE EXTENSION STUDY GIVEN LOWER MONTHLY DOSE OR QUARTERLY DOSE OF ...Reuters
Tue, Jan 13
Senior Russian official says Greenland could vote to join Russia if Trump does not hurry
Jan 13 (Reuters) - Russian Security Council Deputy Chairman Dmitry Medvedev said Greenlanders could vote to join Russia if U.S. President Donald Trump did not move quickly to secure the Arctic island, Interfax reported on Monday.“Trump needs to hurry. According to unverified information, in a few daReuters
Tue, Jan 13
Energy Transfer LP Announces Pricing Of $3.0 Billion Of Senior Notes
Jan 12 (Reuters) - Energy Transfer LP ET.N:ENERGY TRANSFER LP ANNOUNCES PRICING OF $3.0 BILLION OF SENIOR NOTESENERGY TRANSFER LP - PRICES $1.0 BILLION 4.550% SENIOR NOTES DUE 2031ENERGY TRANSFER LP - PRICES $1.0 BILLION 5.350% SENIOR NOTES DUE 2036ENERGY TRANSFER LP - PRICES $1.0 BILLION 6.300% SEN...Reuters
Tue, Jan 13
Appetite for weight-loss deals broader than visible, Viking CEO says
By Puyaan SinghJan 12 (Reuters) - Weight-loss drug developer Viking Therapeutics VKTX.O CEO said on Monday that strategic interest in weight-loss drug deals is broader than it appears, as drugmakers seek to tap into the potential $150 billion market.Pharmaceutical companies are targeting the booming...Reuters
Tue, Jan 13
Amgen's MariTide phase 2 study shows 'meaningful' reduction in blood sugar, weight
Jan 12 (Reuters) - Amgen AMGN.O said on Monday a 24-week study of monthly doses of its experimental obesity drug MariTide in people with type 2 diabetes showed "robust and clinically meaningful" reduction in both blood sugar and weight.In a 52-week extension study, a large majority of partic...Reuters
Tue, Jan 13
Blackrock Cuts Hundreds Of Jobs, Trimming About 1% Of Staff - Bloomberg News
Jan 12 (Reuters) - BLACKROCK CUTS HUNDREDS OF JOBS, TRIMMING ABOUT 1% OF STAFF - BLOOMBERG NEWSBLACKROCK REDUCTIONS AMOUNT TO ABOUT 250 EMPLOYEES FIRMWIDE, INCLUDE MEMBERS OF INVESTMENT AND SALES TEAMS - BLOOMBERG NEWSSource text:Reuters
Tue, Jan 13
Iranians tap Musk's Starlink to skirt internet blackout, sources say
Some Iranians continue to access Starlink, albeit with disruptionsMusk's Starlink has been pivotal in global conflictsStarlink's cost limits access for many IraniansBy Supantha Mukherjee, Cassell Bryan-Low and Parisa Hafezi Jan 12 (Reuters) - Some Iranians are still using Elon Musk’s Star...Reuters
Mon, Jan 12
Abbvie, US reach agreement to cut drug prices
Jan 12 (Reuters) - Abbvie ABBV.N reached a three-year agreement with U.S. President Donald Trump's administration to provide low prices in Medicaid through TrumpRx, and pledged $100 billion over the next decade for research and development in the U.S., the company said on Monday.Reuters
Mon, Jan 12
Amgen to announce data on obesity drug MariTide at healthcare conference
By Michael Erman and Deena Beasley SAN FRANCISCO, Jan 12 (Reuters) - Amgen's AMGN.O research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on Monday to unveil results from a mid-stage trial extension designed to show if the medication he...Reuters
Mon, Jan 12
US Senator Mark Kelly sues Pentagon chief Hegseth over demotion threats
By Mike Scarcella WASHINGTON, Jan 12 (Reuters) - U.S. Senator Mark Kelly sued U.S. Defense Secretary Pete Hegseth on Monday, saying Pentagon proceedings to demote the Arizona Democrat from his retired Navy captain rank violated Kelly's free speech rights because he urged troops to reject unla...Reuters
Mon, Jan 12
Alaska fires law firm in PFAS chemicals case
By David Thomas Jan 12 (Reuters) - The state of Alaska has again terminated a contract with a national plaintiffs' law firm over claims that it violated conflict-of-interest provisions, this time in litigation over firefighting foam chemicals that allegedly contaminated water supplies. Dal...Reuters
Mon, Jan 12
Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court
By Jonathan Stempel Jan 12 (Reuters) - Johnson & Johnson JNJ.N convinced Delaware's highest court to throw out part of a $1 billion damages award for breaching its 2019 agreement to buy Auris Health, a maker of surgical robots.In a unanimous decision on Monday, Delaware's Supreme Cour...Reuters
Mon, Jan 12
Four migrants die in US immigration custody over first 10 days of 2026
Trump administration increases migrant detentions, aims for more deportationsDHS says death rate aligns with historic norms amid rising detentionsBy Ted Hesson WASHINGTON, Jan 12 (Reuters) - Four migrants died while in custody of U.S. immigration authorities over the first 10 days of 2026, accord...Reuters
Mon, Jan 12
Thermo Fisher Scientific Announces Strategic Collaboration With Nvidia
Jan 12 (Reuters) - Thermo Fisher Scientific Inc TMO.N:THERMO FISHER SCIENTIFIC ANNOUNCES STRATEGIC COLLABORATION WITH NVIDIA LEVERAGING AI TO ADVANCE SCIENTIFIC INSTRUMENTATION AND ACCELERATE LABORATORY PERFORMANCEReuters
Mon, Jan 12
